Stefanie M. Bode‐Böger

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction

Rainer H. Böger, Stefanie M. Bode‐Böger, Andrzej Szuba et al. · Circulation · 1998 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacology +12

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci et al. · The Lancet · 2001 · 1.1K citations

Medicine, Nephrology, Pharmacology +8

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Rainer H. Böger, Stefanie M. Bode‐Böger, W Thiele et al. · Circulation · 1997 · 492 citations

Medicine, Cardiology, Pharmacology +12

LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells

Rainer H. Böger, Karsten Sydow, Jürgen Borlak et al. · Circulation Research · 2000 · 482 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

Jan T. Kielstein, Burcu Impraim, S. Simmel et al. · Circulation · 2003 · 404 citations · Full text

Medicine, Cardiology, Pharmacology +12